Author Archive

Please find here the Belgian 2024 Guidance on the use of Pre-Exposure Prophylaxis

Belgian 2024 Guidance on the use of Pre-Exposure Prophylaxis

Belgian 2024 Guidance on the use of Pre-Exposure Prophylaxis Supplementary data

Prevention of Sexually Transmitted Infection remain a major challenge.

In this context we would like to share with you a statement recently issued by BREACH

Please helping us to inform the medical community

DoxyPEP BREACH statement

We wish you all the best for 2023 !
Enjoy the winter holidays !
But before leaving, here are some news about the BREACH activities!

Please read it as we need you !

1/ BREACH Symposium 2022
More than 200 participants
The Speakers, the program and the technical support were well evaluated.

2/ SPRING meeting 2023 ...

Dear all,

Starting in 2022, the King Baudouin Foundation (KBF) and the Belgian HIV Research Consortium (BREACH) have put in place a collaborative process aiming to provide a significant financial support to research projects in the field of HIV developped by Belgian teams.

With the support of the industry, this BREACH / KBF initiative will allow to provide a total of 360 000 Euros for this first call.

The 2022 call which is launched today aims to support research projects in ...

Version en français :

L’ECDC/AAE/EATG a lancé la toute première enquête européenne sur la stigmatisation liée au VIH.

L’objectif de cette enquête est d’interroger les personnes vivant avec le VIH en Europe et en Asie centrale sur leur expérience de la stigmatisation. Mettre fin à la stigmatisation est l’un des principaux objectifs de développement durable, et à ce jour, des mesures à l’échelle régionale pour évaluer les progrès vers la réalisation de cet objectif ne sont pas disponibles. ...

Dear colleagues, 

Every year in September, the HIV Cure Research Center organized a lively HIV-oriented symposium in the picturesque city of Ghent, Belgium. Since the pandemic outbreak of SARS-CoV-2 in 2020, the lab has also invested heavily in the initiation of key research in COVID-19. Therefore, for the second year in a row, we decided to organize an HIV and SARS-CoV-2 ...